cases says guidelines emergency approval covid vaccines food drug administration said efficacy trials include 5 severe cases placebo group gain approval vaccines uncertainties remain not clear long vaccine protective effects block people transmitting virus vaccine works higher risk groups older adults company reported 95 cases 15 people 65 not indicate arm trial participants key question infections vaccinated individuals occurred people 65 says evans indicate vaccine effective group compared thinks unlikely based data showing older participants generate strong immune response vaccine press release moderna said preliminary analysis suggests broadly consistent safety efficacy profile evaluated subgroups researchers buoyed moderna announcement vaccine remains